Understanding lupus nephritis: diagnosis, management, and treatment options

References

• MokCCLauCSPathogenesis of systemic lupus erythematosusJ Clin Pathol20035648149012835292
   PubMed Web of Science ®Google Scholar
• OliverJESilmanAJWhy are women predisposed to autoimmune rheumatic diseases?Arthritis Res Ther20091125219863777
   PubMed Web of Science ®Google Scholar
• MokCCWongWSLauCSLupus nephritis in Southern Chinese patients: clinicopathologic findings and long-term outcomeAm J Kidney Dis19993431532310430980
   PubMed Web of Science ®Google Scholar
• CrossJJayneDDiagnosis and treatment of kidney diseaseBest Pract Res Clin Rheumatol20051978579816150403
   PubMed Web of Science ®Google Scholar
• MokCCBiomarkers for lupus nephritis: a critical appraisalJ Biomed Biotechnol Epub April 19, 2010
   Google Scholar
• MokCCTangSSToCHPetriMIncidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groupsArthritis Rheum2005522774278216142761
   PubMed Web of Science ®Google Scholar
• DooleyMAHoganSJennetteCFalkRCyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative NetworkKidney Int199751118811959083285
   PubMed Web of Science ®Google Scholar
• BastianHMRosemanJMMcGwinGJrLUMINA Study GroupLUpus in MInority populations: NAture vs nurture. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosisLupus20021115216012004788
   PubMed Web of Science ®Google Scholar
• MokCCTangSKIncidence and predictors of renal disease in Chinese patients with systemic lupus erythematosusAm J Med200411779179515541328
   PubMed Web of Science ®Google Scholar
• Christopher-StineLSiednerMLinJRenal biopsy in lupus patients with low levels of proteinuriaJ Rheumatol20073433233517183619
   PubMed Web of Science ®Google Scholar
• DonadioJVJrHartGMBergstralhEJHolleyKEPrognostic determinants in lupus nephritis: a long-term clinicopathologic studyLupus199541091157795613
   PubMed Web of Science ®Google Scholar
• BonoLCameronJSHicksJAThe very long-term prognosis and complications of lupus nephritis and its treatmentQJM19999221121810396609
   PubMed Web of Science ®Google Scholar
• NeumannKWallaceDJAzenCLupus in the 1980s: III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single centerSemin Arthritis Rheum19952547558525390
   PubMed Web of Science ®Google Scholar
• BakirAALevyPSDuneaGThe prognosis of lupus nephritis in African-Americans: a retrospective analysisAm J Kidney Dis1994241591718048420
   PubMed Web of Science ®Google Scholar
• NossentHCKoldingsnesWLong-term efficacy of azathioprine treatment for proliferative lupus nephritisRheumatology (Oxford)20003996997410986301
   PubMed Web of Science ®Google Scholar
• KorbetSMLewisEJSchwartzMMReichlinMEvansJRohdeRDFactors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study GroupAm J Kidney Dis20003590491410793026
   PubMed Web of Science ®Google Scholar
• MokCCPrognostic factors in lupus nephritisLupus200514394415732286
   PubMed Web of Science ®Google Scholar
• MokCCYingKYNgWLLong-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamideAm J Med20061194355. e25e3316564783
   PubMed Web of Science ®Google Scholar
• MokCCWongRWLaiKNTreatment of severe proliferative lupus nephritis: the current stateAnn Rheum Dis20036279980412922948
   PubMed Web of Science ®Google Scholar
• MokCCBirminghamDJLeungHWHebertLASongHRovinBHVitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosisRheumatology (Oxford)20125164465221719424
   PubMed Web of Science ®Google Scholar
• WeeningJJD’AgatiVDSchwartzMMSeshanSVAlpersCEAppelGBThe classification of glomerulonephritis in systemic lupus erythematosus revisitedJ Am Soc Nephrol20041524125014747370
   PubMed Web of Science ®Google Scholar
• MokCCCheungTTLoWHMinimal mesangial lupus nephritis: a systematic reviewScand J Rheumatol20103918118920166847
   PubMed Web of Science ®Google Scholar
• AustinHAIIIKlippelJHBalowJETherapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugsNew Engl J Med19863146146193511372
   PubMed Web of Science ®Google Scholar
• GourleyMFAustinHA3rdScottDMethylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trialAnn Intern Med19961255495578815753
   PubMed Web of Science ®Google Scholar
• IlleiGGAustinHACraneMCombination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritisAnn Intern Med200113524825711511139
   PubMed Web of Science ®Google Scholar
• MokCCLauCSWongRWSRisk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapyArthritis Rheum1998418318379588734
   PubMed Web of Science ®Google Scholar
• MokCCHoCTSiuYPTreatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimensAm J Kidney Dis20013825626411479150
   PubMed Web of Science ®Google Scholar
• MokCCHoCTKChanKWOutcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprineArthritis Rheum2002461003101311953978
   PubMed Web of Science ®Google Scholar
• HoussiauFAVasconcelosCD’CruzDThe 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamideAnn Rheum Dis201069616419155235
   PubMed Web of Science ®Google Scholar
• TangZWangZZhangHTClinical features and renal outcome in lupus patients with diffuse crescentic glomerulonephritisRheumatol Int200930454919387649
   PubMed Web of Science ®Google Scholar
• AppelGBContrerasGDooleyMAAspreva Lupus Management Study GroupMycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritisJ Am Soc Nephrol2009201103111219369404
   PubMed Web of Science ®Google Scholar
• GrootscholtenCLigtenbergGHagenECDutch Working Party on Systemic Lupus Erythematosus. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trialKidney Int20067073274216820790
   PubMed Web of Science ®Google Scholar
• BaoHLiuZHXieHLHuWXZhangHTLiLSSuccessful treatment of class V+IV lupus nephritis with multitarget therapyJ Am Soc Nephrol2008192001201018596121
   PubMed Web of Science ®Google Scholar
• ChenWTangXLiuQShort-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: a multicenter randomized clinical trialAm J Kidney Dis20115723524421177013
   PubMed Web of Science ®Google Scholar
• MokCCYingKYTongKHMycophenolate mofetil versus tacrolimus for active lupus nephritis: an extended observation of a randomized controlled trialArthritis Rheum200858Suppl 9S566
   Google Scholar
• RovinBHFurieRLatinisKLUNAR Investigator GroupEfficacy and safety of rituximab in patients with active proliferative lupus nephritis: the lupus nephritis assessment with rituximab (LUNAR) studyArthritis Rheum2012In press
   Web of Science ®Google Scholar
• JónsdóttirTGunnarssonIMourãoAFLuTYvan VollenhovenRFIsenbergDClinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohortsRheumatology (Oxford)2010491502150420427294
   PubMed Web of Science ®Google Scholar
• MelanderCSalléeMTrollietPRituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcomeClin J Am Soc Nephrol2009457958719261822
   PubMed Web of Science ®Google Scholar
• Vigna-PerezMHernández-CastroBParedes-SaharopulosOClinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot studyArthritis Res Ther20068R8316677395
   PubMed Web of Science ®Google Scholar
• IlleiGGTakadaKParkinDRenal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term follow-up of a cohort of 145 patients participating in randomized controlled studiesArthritis Rheum200246995100211953977
   PubMed Web of Science ®Google Scholar
• MoroniGDoriaAMoscaMA randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four yearsClin J Am Soc Nephrol2006192593217699309
   PubMed Web of Science ®Google Scholar
• ContrerasGPardoVLeclercqBSequential therapies for proliferative lupus nephritisN Engl J Med200435097198014999109
   PubMed Web of Science ®Google Scholar
• MoroniGGallelliBQuagliniSWithdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-upNephrol Dial Transplant2006211541154816455674
   PubMed Web of Science ®Google Scholar
• HoussiauFAD’CruzDSangleSMAINTAIN nephritis trial groupAzathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis TrialAnn Rheum Dis2010692083208920833738
   PubMed Web of Science ®Google Scholar
• DooleyMAJayneDGinzlerEMMycophenolate versus azathioprine as maintenance therapy for lupus nephritisN Engl J Med20113651886189522087680
   PubMed Web of Science ®Google Scholar
• MokCCMembranous nephropathy in systemic lupus erythematosus: a therapeutic enigmaNat Rev Nephrol2009521222019322186
   PubMed Web of Science ®Google Scholar
• AustinHA3rdIlleiGGBraunMJBalowJERandomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathyJ Am Soc Nephrol20092090191119297556
   PubMed Web of Science ®Google Scholar
• GinzlerEMDooleyMAAranowCMycophenolate mofetil or intravenous cyclophosphamide for lupus nephritisN Engl J Med20053532219222816306519
   PubMed Web of Science ®Google Scholar
• RadhakrishnanJMoutzourisDAGinzlerEMSolomonsNSiemposIIAppelGBMycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritisKidney Int20107715216019890271
   PubMed Web of Science ®Google Scholar